LONDON - The industry is promised a new treasure trove of targets by the latest sequencing effort, the $50 million 1000 Genomes Project, launched last week by an international public sector consortium. (BioWorld Today)

Research Council, GSK Join in Effort to Find Drug Targets

By Nuala Moran

Wednesday, January 30, 2008

Buy Reprint

No Abstract

Human Cell Model Study to Illuminate the Circadian Clock

By Sharon Kingman

Wednesday, January 30, 2008

Buy Reprint

No Abstract

MolMed Starting Phase III Trial of T-Cell Therapy

By Cormac Sheridan

Wednesday, January 30, 2008

Buy Reprint

No Abstract

BioWorld

Store

Others

BioWorld-International-2008-01-30

EU Research Chief Enters Debate by Pushing Biofuels Production

Endotis Pharma Raises €25M to Move Small Glyco-Drugs

Other News To Note

$50M Sequence Project to Map Genomes in 1,000 People

Research Council, GSK Join in Effort to Find Drug Targets

Human Cell Model Study to Illuminate the Circadian Clock

MolMed Starting Phase III Trial of T-Cell Therapy

Explore BioWorld.com

BioWorld

Store

Others

Login to Your Account

BioWorld

Store

Others

BioWorld-International-2008-01-30

EU Research Chief Enters Debate by Pushing Biofuels Production

Endotis Pharma Raises €25M to Move Small Glyco-Drugs

Other News To Note

$50M Sequence Project to Map Genomes in 1,000 People

Research Council, GSK Join in Effort to Find Drug Targets

Human Cell Model Study to Illuminate the Circadian Clock

MolMed Starting Phase III Trial of T-Cell Therapy

Explore BioWorld.com

BioWorld

Store

Others